From our survey
What the insurance hoops really are for esketamine treatment
"Covered, but with hoops." The phrase makes people sigh, yet it is the route people pick. Our poll offered 443 Midwest adults in ten states a choice between an insured depression treatment with extra steps and a self-paid one with fewer, and 51 percent took coverage, 23 percent would pay, and the remaining 26 percent were unsure.
If you are in St. Charles and leaning toward the covered route, it helps to know what the hoops actually are. This explainer takes them one at a time for esketamine, the nasal spray approved when standard depression treatment has failed. Every poll number below is final.
Hoop one: a diagnosis that fits the approval
Insurers generally cover treatments for their approved uses. Spravato's approval centers on adults whose depression resists treatment; its label lists the details. PTSD and anxiety alone are not approved uses.
What it asks of you: A clinician's diagnosis of major depression, and an assessment that it has not responded adequately to standard treatment.
Hoop two: proof of what you have already tried
This is usually the heaviest hoop. Plans typically want records showing that you have tried more than one antidepressant at an adequate dose, for long enough, without enough improvement. They may also want symptom scores from a standardized questionnaire such as the PHQ-9.
What it asks of you: Help your doctor build a complete history. Write down every antidepressant you remember, when you took it, roughly what dose, how long, and why you stopped. Pharmacy records and old patient portal entries can fill gaps.
Hoop three: a psychiatric evaluation
Before prescribing, a psychiatrist or other qualified prescriber at or connected to a certified site will evaluate you. They will look at your history, blood pressure, heart and blood vessel health, substance use, and other factors that affect safety.
What it asks of you: An appointment, which may involve a wait. A referral from your primary doctor can help, and 56 percent of our respondents planned to begin there regardless.
Hoop four: prior authorization
Once the prescriber recommends esketamine, the clinic usually submits a prior authorization request to your insurer with the documentation from hoops one through three. The insurer reviews it and approves or denies.
What it asks of you: Patience, and a willingness to follow up. Ask the clinic how long approvals typically take with your plan, and who to call for updates.
If it is denied: Denials are often about missing information. The clinic can usually appeal or request a peer-to-peer review between the prescriber and the insurer's physician. Do not assume a first denial is final.
Hoop five: an in-network certified site
Only clinics certified under the esketamine safety program may give it, and for coverage the clinic must also be in your network.
What it asks of you: Phone your plan and ask which certified clinics around St. Charles it covers. Some are in St. Charles County; others are in St. Louis County or the city. Distance matters, since early treatment involves frequent visits and you will need a ride home each time.
Hoop six: understanding which benefit pays
Depending on your plan and the clinic, esketamine may fall under your medical benefit or your pharmacy benefit. The observation visit after each dose is billed separately. This affects your copays and deductibles.
What it asks of you: Ask the clinic's billing staff to estimate your per-session out-of-pocket cost before you start. Brain Recovery Centers also explains how esketamine costs and coverage usually work, which can make that conversation easier.
Hoop seven: reauthorization
Many plans approve treatment for a defined period and then ask for evidence that it is helping before approving more. Your clinician tracks symptom scores partly for this reason.
A hoop that is not about insurance
Separately from coverage, the drug's federal safety program requires you to enroll, to stay on site for monitoring after each dose, and not to drive until the next day. These apply whether you pay yourself or use insurance.
Why so many people choose the hoops anyway
Coverage mattered enormously to our respondents: 85 percent listed insurance among two provider priorities, and 65 percent said it could decide, or weigh heavily on, trying the treatment. For many, especially the 37 percent of respondents who reported Medicaid coverage, paying out of pocket for repeated sessions may not be realistic.
The self-pay options people have in mind are often different treatments altogether, such as off-label IV ketamine infusions or at-home ketamine from online services. Those can involve fewer hoops, but they are not the same as the approved nasal spray, and supervision is lighter.
A folder that clears most of the hoops
Nearly every hoop asks for the same things, so keep them together: your insurance card, your plan's phone number, your medication history, your doctors' names, and a log of each call with its date and whoever answered. Requests then take minutes, not days.
The short version
The hoops are real, but they are mostly paperwork and patience: a diagnosis, a documented medication history, an evaluation, an approval, and an in-network site. The best thing you can do is start the medication history today.
Nothing here is medical or insurance advice. Coverage rules vary by plan, and suitability for treatment is a clinician's decision.
Paperwork should never delay help in an emergency. With thoughts of suicide, reach for 988 by phone or text before any form; it costs nothing, and the people staffing the Suicide and Crisis Lifeline pick up at every hour of every day.
Methodology
Respondents to Pollfish survey 395586438 came from its consumer panel, and fieldwork closed June 23, 2026, at 443 completes, every person 18 to 64 in Ohio, Illinois, Oklahoma, Missouri, Nebraska, Indiana, Kansas, Minnesota, Wisconsin or Iowa. The payer question allowed several answers. Figures are final, whole-sample shares. Our publisher requested and funded the survey.